Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Cash & Equivalents (2020 - 2025)

GoHealth (GOCO) has disclosed Cash & Equivalents for 6 consecutive years, with $32.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 19.59% to $32.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.9 million through Dec 2025, down 19.59% year-over-year, with the annual reading at $32.9 million for FY2025, 19.59% down from the prior year.
  • Cash & Equivalents hit $32.9 million in Q4 2025 for GoHealth, up from $32.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $215.4 million in Q3 2022 to a low of $14.1 million in Q2 2024.
  • Historically, Cash & Equivalents has averaged $69.0 million across 5 years, with a median of $38.3 million in 2024.
  • Biggest YoY gain for Cash & Equivalents was 451.56% in 2023; the steepest drop was 87.75% in 2023.
  • Year by year, Cash & Equivalents stood at $84.4 million in 2021, then plummeted by 80.48% to $16.5 million in 2022, then skyrocketed by 451.56% to $90.8 million in 2023, then tumbled by 54.94% to $40.9 million in 2024, then dropped by 19.59% to $32.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for GOCO at $32.9 million in Q4 2025, $32.1 million in Q3 2025, and $35.6 million in Q2 2025.